Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,609
Total Claims
$1.2M
Drug Cost
504
Beneficiaries
$2,388
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-95%
Opioid rate vs peers
0.2% vs 3.8% avg
+103%
Cost per patient vs peers
$2,388 vs $1,174 avg
+41%
Brand preference vs peers
12.5% vs 8.9% avg
Opioid Prescribing
0.2%
Opioid Rate
16
Opioid Claims
$51
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,072 claims · $1.0M
Generic: 7,475 claims · $190K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 91 | $159K |
| Semaglutide | 56 | $112K |
| Fluticasone/Umeclidin/Vilanter | 55 | $90K |
| Empagliflozin | 57 | $67K |
| Dapagliflozin Propanediol | 37 | $65K |
| Apixaban | 43 | $58K |
| Sitagliptin Phosphate | 25 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $34K |
| Semaglutide | 22 | $30K |
| Tirzepatide | 20 | $27K |
| Rivaroxaban | 28 | $25K |
| Linaclotide | 28 | $24K |
| Mirabegron | 28 | $22K |
| Linagliptin | 11 | $18K |
| Evolocumab | 14 | $16K |
Prescribing Profile
Patient Profile
70
Avg Age
64%
Female
1.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data